(a) Whole-cell currents in response to a family of voltage steps from −80 to 0 mV in 5 mV steps. (b) A-type current separated from other outward current components. The remaining step-evoked current following a pre-pulse (−30 mV, 200 ms) capable of inactivating A-type current was subtracted from total current. Voltage steps from −50 to +40 in 10 mV steps. Recordings were carried out in the presence of 5 mM TEA in order to block slowly activating K+ currents. (c) Voltage-dependence of steady-state activation and inactivation. (d) Activation (red) and inactivation (blue) time constants of dissected A-type current (top) and recovery of inactivation time constant (bottom). (e) The fast inactivating outward current found in these cells was sensitive to the A-type current blocker 4-AP (7 mM) and the Kv4-specific blocker phrixotoxin (PhTX, 5 µM). Top panels: total currents in control, drug application, and washout, as indicated. Lower panel: PhTX block of transient outward current fraction, separated as in (b). (f) Average of 537 aligned APs following ISIs lasting longer than 100 ms shows a small prespike dip or inflection, attributed to the activation of the transient K+ current. (g), (i) Isolated transient outward current with a single exponential fitted to the decay phase (τ = 13.05 ms). (ii) Example current from a cluster of transient K+ channels in a cell-attached patch (step from RP-30 mV to RP+50 mV at the time indicated by arrow, outward current plotted upwards), fitted with the same exponential time constant as in (i). (h) Dependence of patch current on the potential of a 500 ms prepulse before a step from RP-30 to RP+50 mV, showing that it inactivates over the range RP+10 mV to RP+40 mV.
DOI:
http://dx.doi.org/10.7554/eLife.16475.009